|
〔1〕AndoKTakashiMoriyamaLucaGguidottietal MachanismsofClassⅠRestrictedImmunopathologyATransgenicMouseModelofFulminantHepati tisJExpMed , 1993 , 78∶15 41
|
|
〔2〕黄自存 , 张国良 , 周大 , 等 胸腺肽α1 联合干扰素α1 b治疗慢性病毒性乙、丙型肝炎 中国新药杂志 , 1997, 2∶90
|
|
〔3〕BaumannCABadamchianMGoldsteinAl ( 195 5 ) Tα1 antagonizesinducedapoplosisofdevelopingthymocytesinvitroMolCellBiol啨s 毢啨a (abstract2 0 72 )
|
|
〔4〕SekiyamaKDyoshibaMThomsonAWetal Circulatingproinflammatorycytokines (IL -1pTNFαandIL -6) andIL -1receptorantagonist (IL -ΙRa) infulminantHepaticfailureClinExpImmunol 1994。 98∶71
|
|
〔5〕FrancescoPDGaziano -RCombinedeffectoffluconasoleandthymosincα1 onsystemiccandidasisinmiceImmunopressedbymorphineTreatmentsClinExpImmunol 1994。paper 42 6
|
|
〔6〕FukudaRIshimuraNNguyenTXetal TheexpressionofIL -2IL -4andInterferongam (IFNr) mRNAUsingliver, biopsisatdifferentphaseofa cutexacerbationofChronicHepatitisBClinExpImmunol1995。 10 0∶446
|
|
[]〔7〕裕石明 , 张立煌 , 方梅林。等 IL -4对重症肝炎患者外周血单核细胞IL -1α表达调节研究 , 中华传染病杂志 , 1998, 16 ( 3 ) ∶14 4
|